Abaloparatide, a novel osteoanabolic PTHrP analog, increases cortical and trabecular bone mass and architecture in orchiectomized rats by increasing bone formation without increasing bone resorption-Reference-Cited by-同舟云学术

Abaloparatide, a novel osteoanabolic PTHrP analog, increases cortical and trabecular bone mass and architecture in orchiectomized rats by increasing bone formation without increasing bone resorption

Published:2019-03 Issue: Volume:120 Page:148-155
ISSN:8756-3282
Container-title:Bone
language:en
Short-container-title:Bone

Author:

Chandler Heidi,Lanske Beate,Varela Aurore,Guillot Martin,Boyer Marilyne,Brown Jeffrey,Pierce Allen,Ominsky Michael,Mitlak Bruce,Baron Roland,Kostenuik Paul,Hattersley Gary

Funder

Radius Health

Harvard School of Dental Medicine

Publisher

Elsevier BV

Subject

Histology,Physiology,Endocrinology, Diabetes and Metabolism

Reference38 articles.

1. Male hypogonadism and osteoporosis: the effects, clinical consequences, and treatment of testosterone deficiency in bone health;Golds;Int. J. Endocrinol.,2017

2. Androgen-deprivation-associated bone disease;Skolarus;Curr. Opin. Urol.,2014

3. Mineralization and bone resorption are regulated by the androgen receptor in male mice;Chiang;J. Bone Miner. Res.,2009

4. Suppressive function of androgen receptor in bone resorption;Kawano;Proc. Natl. Acad. Sci. U. S. A.,2003

5. Male Osteoporosis;Drake;Endocrinol. Metab. Clin. N. Am.,2012

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress in Organ Bioprinting for Regenerative Medicine—Article;Engineering;2024-06

2. Abaloparatide promotes bone repair of vertebral defects in ovariectomized rats by increasing bone formation;Bone;2024-05

3. Targeted Delivery of Abaloparatide to Spinal Fusion Site Accelerates Fusion Process in Rats;Biomedicines;2024-03-08

4. Insights into the Mechanism of Osteoporosis and the Available Treatment Options;Current Pharmaceutical Biotechnology;2023-11-02

5. Comparative study in estrogen-depleted mice identifies skeletal and osteocyte transcriptomic responses to abaloparatide and teriparatide;JCI Insight;2023-10-23